175 related articles for article (PubMed ID: 11841484)
1. Influence of TNFalpha and LTalpha single nucleotide polymorphisms on susceptibility to and prognosis in cutaneous malignant melanoma in the British population.
Howell WM; Turner SJ; Collins A; Bateman AC; Theaker JM
Eur J Immunogenet; 2002 Feb; 29(1):17-23. PubMed ID: 11841484
[TBL] [Abstract][Full Text] [Related]
2. Cytokine gene single nucleotide polymorphisms and susceptibility to and prognosis in cutaneous malignant melanoma.
Howell WM; Turner SJ; Theaker JM; Bateman AC
Eur J Immunogenet; 2003 Dec; 30(6):409-14. PubMed ID: 14675394
[TBL] [Abstract][Full Text] [Related]
3. MHC class II, tumour necrosis factor alpha, and lymphotoxin alpha gene haplotype associations with serological subsets of systemic lupus erythematosus.
McHugh NJ; Owen P; Cox B; Dunphy J; Welsh K
Ann Rheum Dis; 2006 Apr; 65(4):488-94. PubMed ID: 16107511
[TBL] [Abstract][Full Text] [Related]
4. Modulation of type 1 diabetes susceptibility by tumor necrosis factor alpha -308 G/A and lymphotoxin alpha +249 A/G haplotypes and lack of linkage disequilibrium with predisposing DQB1-DRB1 haplotypes in Bahraini patients.
Stayoussef M; Al-Jenaidi FA; Al-Abbasi A; Al-Ola K; Khayyat H; Mahjoub T; Almawi WY
Clin Vaccine Immunol; 2008 Feb; 15(2):379-81. PubMed ID: 17989340
[TBL] [Abstract][Full Text] [Related]
5. IL-10 promoter polymorphisms influence tumour development in cutaneous malignant melanoma.
Howell WM; Turner SJ; Bateman AC; Theaker JM
Genes Immun; 2001 Feb; 2(1):25-31. PubMed ID: 11294564
[TBL] [Abstract][Full Text] [Related]
6. HLA-DQB1*0303 and *0301 alleles influence susceptibility to and prognosis in cutaneous malignant melanoma in the British Caucasian population.
Bateman AC; Turner SJ; Theaker JM; Howell WM
Tissue Antigens; 1998 Jul; 52(1):67-73. PubMed ID: 9714476
[TBL] [Abstract][Full Text] [Related]
7. Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumour development in cutaneous malignant melanoma.
Howell WM; Bateman AC; Turner SJ; Collins A; Theaker JM
Genes Immun; 2002 Jun; 3(4):229-32. PubMed ID: 12058259
[TBL] [Abstract][Full Text] [Related]
8. EGF +61 gene polymorphism and susceptibility to and prognostic markers in cutaneous malignant melanoma.
McCarron SL; Bateman AC; Theaker JM; Howell WM
Int J Cancer; 2003 Nov; 107(4):673-5. PubMed ID: 14520709
[TBL] [Abstract][Full Text] [Related]
9. Independent and additive interaction between polymorphisms of tumor necrosis factor α-308 and lymphotoxin α+252 on risk of hepatocellular carcinoma related to hepatitis B.
Tsai JF; Chen SC; Lin ZY; Dai CY; Huang JF; Yu ML; Chuang WL
Kaohsiung J Med Sci; 2017 Sep; 33(9):453-457. PubMed ID: 28865603
[TBL] [Abstract][Full Text] [Related]
10. ICAM-1 polymorphisms and development of cutaneous malignant melanoma.
Howell WM; Rose-Zerilli MJ; Theaker JM; Bateman AC
Int J Immunogenet; 2005 Dec; 32(6):367-73. PubMed ID: 16313300
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor alpha and lymphotoxin alpha haplotypes in idiopathic recurrent pregnancy loss.
Zammiti W; Mtiraoui N; Finan RR; Almawi WY; Mahjoub T
Fertil Steril; 2009 May; 91(5):1903-8. PubMed ID: 18394614
[TBL] [Abstract][Full Text] [Related]
12. Relation between tumour necrosis factor polymorphism TNFalpha-308 and risk of asthma.
Witte JS; Palmer LJ; O'Connor RD; Hopkins PJ; Hall JM
Eur J Hum Genet; 2002 Jan; 10(1):82-5. PubMed ID: 11896460
[TBL] [Abstract][Full Text] [Related]
13. Impact of TNF-α and LTα gene polymorphisms on genetic susceptibility in Indian SLE patients.
Umare VD; Pradhan VD; Rajadhyaksha AG; Patwardhan MM; Ghosh K; Nadkarni AH
Hum Immunol; 2017 Feb; 78(2):201-208. PubMed ID: 27838362
[TBL] [Abstract][Full Text] [Related]
14. MHC loci affecting cervical cancer risk: distinguishing the effects of HLA-DQB1 and non-HLA genes TNF, LTA, TAP1 and TAP2.
Ivansson EL; Magnusson JJ; Magnusson PK; Erlich HA; Gyllensten UB
Genes Immun; 2008 Oct; 9(7):613-23. PubMed ID: 18650831
[TBL] [Abstract][Full Text] [Related]
15. Association between non-Hodgkin lymphoma and haplotypes in the TNF region.
Spink CF; Keen LJ; Mensah FK; Law GR; Bidwell JL; Morgan GJ
Br J Haematol; 2006 May; 133(3):293-300. PubMed ID: 16643431
[TBL] [Abstract][Full Text] [Related]
16. Linkage disequilibrium with predisposing DR3 haplotypes accounts for apparent effects of tumor necrosis factor and lymphotoxin-alpha polymorphisms on type 1 diabetes susceptibility.
Noble JA; Valdes AM; Lane JA; Green AE; Erlich HA
Hum Immunol; 2006 Dec; 67(12):999-1004. PubMed ID: 17174749
[TBL] [Abstract][Full Text] [Related]
17. Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associations.
Waterer GW; Quasney MW; Cantor RM; Wunderink RG
Am J Respir Crit Care Med; 2001 Jun; 163(7):1599-604. PubMed ID: 11401880
[TBL] [Abstract][Full Text] [Related]
18. Association of tumour necrosis factor-alpha, lymphotoxin-alpha and HLA-DRB1 gene polymorphisms with Löfgren's syndrome in Czech patients with sarcoidosis.
Mrazek F; Holla LI; Hutyrova B; Znojil V; Vasku A; Kolek V; Welsh KI; Vacha J; du Bois RM; Petrek M
Tissue Antigens; 2005 Feb; 65(2):163-71. PubMed ID: 15713215
[TBL] [Abstract][Full Text] [Related]
19. High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment.
Davies FE; Rollinson SJ; Rawstron AC; Roman E; Richards S; Drayson M; Child JA; Morgan GJ
J Clin Oncol; 2000 Aug; 18(15):2843-51. PubMed ID: 10920132
[TBL] [Abstract][Full Text] [Related]
20. Associations of 9p21 variants with cutaneous malignant melanoma, nevi, and pigmentation phenotypes in melanoma-prone families with and without CDKN2A mutations.
Yang XR; Liang X; Pfeiffer RM; Wheeler W; Maeder D; Burdette L; Yeager M; Chanock S; Tucker MA; Goldstein AM
Fam Cancer; 2010 Dec; 9(4):625-33. PubMed ID: 20574843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
